-binding proteins, adenosine triphosphate (ATP), thiol modification, phosphorylation and interacting proteins, and of IP 3 R-isoform specific expression patterns. Second, we will discuss the role of the ER as a Ca 2+ store in cell death and survival and how IP 3 Rs and pro-survival/pro-death proteins can modulate the basal ER Ca 2+ leak. Third, we will review the regulation of the Ca 2+ -flux properties of the IP 3 R isoforms by the ER-resident and by the cytoplasmic proteins involved in cell death and survival as well as by redox regulation. Hence, we aim to highlight the specific roles of the various IP 3 R isoforms in cell-death and -survival signaling.
Introduction
The IP 3 R is the most ubiquitous intracellular Ca 2+ channel and is represented in vertebrates by three different isoforms (IP 3 R1, IP 3 R2 and IP 3 R3) with 60-80% homology in their amino acid (a.a.) sequences. They are encoded by different genes and further isoform diversity is introduced by the existence of alternative splice forms [1, 2] . IP 3 R1 has three splice sites, namely S1, S2 (below we will refer with S2 − to the short peripheral form and with S2 + to the long neuronal form) and S3. Also for IP 3 R2 and the invertebrate isoforms, splice variants were found (for review see [2] ). IP 3 Rs exist as tetramers and evidence for an additional level of channel diversity, generated by heterotetrameric interactions among different isoforms, came from co-immunoprecipitation experiments [3, 4] and from cross-linking studies [5] . The functional consequences of heterotetramer formation were recently explored by assembling IP 3 Rs from concatenated homo-and heteromeric subunits [6] . Dimeric constructs were expressed in DT40 triple knock-out (DT40-TKO) cells, an IP 3 R null cell line. IP 3 Rs formed from concatenated dimers were found to be functional and were studied using "on-nucleus" patch clamp. It was found that heterotetramers do not simply behave as a blend of the constitutive subunits. Notably, the activity of channels formed from concatenated IP 3 R1 and IP 3 R2 was dominated by IP 3 R2 [6] . The general domain structure of the IP 3 Rs has been determined and revealed two regions of high homology between the subtypes: the N-terminal region
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[ [7] [8] [9] and the C-terminus with the channel domain and the determinants for tetramer formation [10, 11] . The intervening domain (~1700 a.a.) exhibits more sequence variability between subtypes. This region is named the central, modulatory or coupling domain and it contains interaction sites for many intracellular regulators and interacting proteins [1, 2, 4, [12] [13] [14] [15] . By far the largest amount of information about regulatory mechanisms is available for IP 3 R1, while the other subtypes are less extensively documented. Mutational analysis and expression of mutant isoforms in DT40-TKO cells yielded direct information about isoform specificity in basic structure and regulation [13] . The basic regulators of the IP 3 respectively), ATP, thiol modification, and phosphorylation by protein kinases. Furthermore, there is an increasing number of documented interactions with regulatory proteins, including several proteins directly involved in cell-fate regulation. In this review we will give an overview of the role of the IP 3 R in cellfate decisions, with a particular focus on the specific roles of IP 3 R isoforms. First, we will review the best documented cases of differential regulation of the three isoforms by general cellular regulators (Section 2). Following this, a more detailed description of the differential regulation by luminal and cytoplasmic interactors involved in controlling cell death or survival will be given in Sections 3, 4 and 5.
2. Properties and expression patterns of the IP 3 R isoforms 2.1. Differential properties of IP 3 R isoforms 2.1.1. Activation by IP 3 It was found that soluble monomeric proteins representing the Nterminal 788 residues of the IP 3 Rs still retained IP 3 -binding properties [7, 8, 16, 17] . Deletion analysis revealed that the region encompassing residues 226-576 in IP 3 R1 represents the IP 3 -binding core, whereas the region containing residues 1-225 functions as a suppressor of IP 3 binding ( Fig. 1) [9, 18] . Crystal structures of both domains of mouse IP 3 R1 have been published [19] . The N-terminal 604 residues from the three isoforms exhibited IP 3 -binding affinities, that are close to the intrinsic values found for the full-size receptors [20] [21] [22] [23] . The relative affinities were IP 3 R2 N IP 3 R1 N IP 3 R3, with a more than 10-fold difference between IP 3 R2 and IP 3 R3. The binding cores of the three isoforms appeared to have a similar affinity for IP 3 and the suppressor domain was responsible for isoform-specific fine tuning of this affinity [21] . Deletion of the suppressor domain resulted in a significant increase in the IP 3 -binding affinity [9] , but abolished the channel activity of the IP 3 R [24, 25] . The suppressor domain is also directly involved in linking ligand binding to channel gating as was already suggested by earlier biochemical studies [24, 26] . From these early studies, the interaction was proposed to occur between different subunits linking the N-terminus of one subunit to the cytoplasmic loop connecting transmembrane helices 4 and 5 (M4-M5 linker) of an adjacent subunit [27] . Compelling evidence for a critical role of the suppressor domain in channel gating as well as in determining IP 3 sensitivity, was obtained from mutational and structural data for IP 3 R1 and IP 3 R3 [28, 29] . The crystal structure of the suppressor domain of IP 3 R3 has been determined [28] and the suppressor region appeared to be structurally and functionally similar for the different isoforms. In vitro evidence for a direct interaction between the suppressor domain and the M4-M5 linker was obtained, mainly from pull-down experiments with the isolated N-terminus [26] or the suppressor domain [28] . Interestingly, mutations in the suppressor domain (like Y167 in IP 3 R1 and W168 in IP 3 R3) that abolish IP 3 R-channel activity [29] also reduced the binding of the suppressor domain to the M4-M5 linker [28] . Yet, based on recent observations in an elegant study revealing that domains critical for IP 3 R and ryanodine-receptor (RyR) channel function are structurally and functionally conserved between both channels [30] , it was proposed that a direct interaction between the suppressor domain and the M4-M5 linker is not very likely to be the mechanism for gating the pore. This is supported by computational docking studies placing the IP 3 -binding-domain structure into the cryo-electron microscopy map of IP 3 R1, thereby pointing towards an IP 3 R-activation model in which additional cytosolic domains are likely involved in coupling the N-terminal IP 3 -binding domain to the opening of the C-terminal channel pore [30] . In any case, it is clear that both regions are essential for IP 3 R activation although the interaction may be indirect and involving other domains [30, 31] .
Regulation by Ca

2+
The regulation of the function of the IP 3 R is much more complex as the IP 3 R is controlled by both IP 3 and Ca 2+ itself, which are operating as co-agonists [32, 33] . IP 3 ] cyt and an inhibition at higher concentrations [32, [34] [35] [36] . A similar bell-shaped dependence on the [Ca 2+ ] cyt was found for all three IP 3 R subtypes but with clear isoform-specific characteristics regarding the bell shape [23, 37, 38] . IP 3 thereby dynamically changes the sensitivity to [Ca 2+ ] cyt [33, 39] . Different mechanistic models were proposed to explain the regulation of the IP 3 R by these two co-agonists [40, 41] . In these models IP 3 functions as a regulator for either a Ca 2+ -activator site [40] , or as a regulator that decreases the Ca 2+ sensitivity of an inhibitory site [39] . Different types of IP 3 -dependent and IP 3 -independent Ca
-binding sites were proposed [41] [42] [43] , but their exact locations have not been identified. There is evidence for several direct interaction sites for Ca 2+ , some of which are conserved amongst the various isoforms [44] [45] [46] , and for a functional role of the E2100 residue in the Ca 2+ sensitivity [47, 48] . However, the exact mechanistic role of these sites is not clear. These data are also compatible with a single-particle analysis that showed a structural transition induced by Ca 2 + binding from a square to a windmill form [50, 51] . In addition to a regulation by the [Ca 2+ ] cyt , the IP 3 R is also regulated by the Ca 2+ load in the lumen of the ER [52] [53] [54] [55] [56] [57] [58] . This regulation leads to a much decreased sensitivity towards IP 3 at low levels of store filling (b30% filling), helping to prevent excessive ER depletion, which would be detrimental for the cell [59] . There is good evidence from nuclear patch experiments that this effect of the [Ca 2+ ] ER is dependent on permeation of Ca 2+ through the channel and the Ca 2+ sensor may therefore be located at a cytosolic site [60] . In addition, as will be outlined in the next sections, the -binding protein 1 (CaBP1), which both have documented interaction sites with the IP 3 R (Fig. 1) . CaM can bind to a binding site located in the regulatory region of the receptor [63] , to a split N-terminal site [64, 65] , and to a third site created in IP 3 R1 by alternative splicing [66] . CaM inhibits the various IP 3 R isoforms in a Ca 2+ -dependent way [67] [68] [69] [70] [71] , but it is not the Ca 2 + sensor responsible for the biphasic Ca 2 + regulation [64, 72, 73] . A CaM-binding peptide derived from myosin light chain kinase, which comprises a 1-8-14 CaM-binding sequence, was found to inhibit IICR [74] via all three IP 3 R subtypes [75] . A similar conserved 1-8-14 CaM-binding motif was recently identified in the suppressor domain of IP 3 R1. Mimetic peptides specifically inhibit activation of the IP 3 R by uncoupling the IP 3 -binding core from the suppressor domain. It was proposed that the inhibitory effects of CaM may also result from a similar disruption of this interaction [76] . One part of the split N-terminal CaM-binding site of IP 3 R1 also binds CaBP1 [77] . It was found that a much stronger interaction occurred between the Ca 2+ -bound form of CaBP1 and the complete IP 3 -binding domain (residues 1-587), which is in agreement with structural data indicating that CaBP1 binding requires both the suppressor and the ligand-binding core [78] . Recently, an NMR and docking analysis suggested that CaBP1 forms an extended tetrameric turret attached via the IP 3 R1 N-termini to the cytosolic vestibule of the pore [79] . The hydrophobic residues within the C-lobe of CaBP1 that make the essential contacts with the IP 3 -binding core become exposed when CaBP1 binds Ca
. CaBP1 is proposed to stabilize in this arrangement a closed state of the IP 3 R1 channel by clamping the underlying subunits. CaBP1 would bind loosely to the neuronal IP 3 R1 at resting [Ca 2+ ] cyt , whereas Ca 2+ passing through the pore can bind to CaBP1 thereby causing a rapid feedback inhibition [79] .
Regulation by ATP
ATP and other adenine nucleotides were reported to increase the IP 3 R activity at submillimolar concentrations, while higher concentrations are inhibitory [80, 81] . ATP modulates all three IP 3 R isoforms but there are clear isoform-specific characteristics [82] [83] [84] . IP 3 R2 diverged from the other isoforms as it appears to be modulated by ATP only at submaximal IP 3 concentrations [84, 85] . Moreover, IP 3 R2 shows the highest sensitivity of the three isoforms towards modulation by ATP [13, 86] . Interestingly, it was found in pancreatic acinar cells that IP 3 R2 was ten times more sensitive than IP 3 R3 and the IP 3 R2 complement in these cells largely determined the effects of metabolic stress on Ca 2+ signaling [87] . ATP binds to glycine-rich regions (Walker A motif) and the IP 3 R sequence contains several of such motifs ( Fig. 1 ) [2, 15] . One site called ATPB is common to all three isoforms, while two other sites, ATPA and ATPC, the latter being formed upon S2 − splicing, are unique for IP 3 R1 [13] . There is good evidence that these sites in isolation can bind ATP, but the presence of other sites could not be excluded [84, 88, 89] . By systematic mutagenesis of the critical residues and expression of the mutant IP 3 Rs in DT40-TKO cells, the direct functional significance of these different ATP-binding sites has been investigated, leading to some surprising findings [13, 86] . Remarkably, neither the ATPA, nor the ATPB site in IP 3 R1 appeared to be required for the modulation of Ca 2+ release by ATP [85] . It is possible that a novel ATP-binding sequence mediates this effect or that the effect depends on conformational changes or on an accessory protein [13] . Similarly, disruption of the conserved ATPB site in IP 3 R3 did not change the modulation of its activity by ATP [84] . A striking dependence on the ATPB site was found for IP 3 R2, where this site was solely responsible for the functional effects of ATP on Ca 2+ signaling via B cell-receptor activation [84] . Also the role of the ATPC site in the S2 − -splice isoform of IP 3 R1 was investigated by mutational analysis [90] . Binding of ATP to the ATPC site was responsible for a conformational change that made IP 3 R1 susceptible to phosphorylation by protein kinases including protein kinase A (PKA), but not Fig. 1 . Linear representation of the three IP 3 R isoforms and their regulatory mechanisms. The three IP 3 R isoforms are depicted (grey). The three large functional domains present in all three isoforms are indicated at the top. The ligand-binding domain is split into suppressor domain and IP 3 -binding core. The transmembrane domains are indicated as black bars at the C-terminal end. Numbering is based on the murine sequence. Selected regulatory mechanisms discussed in the text (e.g. phosphorylation sites for PKA and PKB/Akt, and binding sites for CaM, CaBP1, Ca 2+ and ATP) are indicated. Distinct differences between the three isoforms are shown on the figure. -binding sites were documented. Two of these sites were shown to be functionally conserved in the other two isoforms, although sequence alignment revealed similarities between the different isoforms at several of these locations. A conserved ATP-binding (ATPB) site is present in all three IP 3 R isoforms. In addition to this site, two unique sites (ATPA and ATPC) were described on IP 3 R1.
for the ATP regulation of the Ca 2+ release per se, which in this isoform must occur by an alternative site [13] .
Regulation by thiol modification
Thiol-modifying agents like thimerosal, affect IP 3 R function in an isoform-specific manner. Thimerosal at low micromolar concentrations promotes IP 3 R-mediated Ca 2+ signaling in a variety of cellular systems, including oocytes [91] , hepatocytes [92, 93] , HeLa cells [94] and A7r5 smooth-muscle cells [36] . Thimerosal displayed a bell-shaped activation of IP 3 R1-mediated Ca 2+ release, with concentrations of thimerosal lower than 10 μM being stimulatory by sensitizing the channels to low IP 3 concentrations and increasing total Ca 2+ flux, while concentrations higher than 10 μM being inhibitory [36, 95] . These effects of thimerosal were selective for IP 3 R1, since IP 3 R3-channel function was not promoted by thimerosal [96] . [99] . The former required the presence of cysteine residues both in the suppressor and in the binding-core domain. Although the cysteine residues responsible for thimerosal-induced IP 3 R1 sensitization remain elusive and further studies are needed, C214 in the suppressor domain and C556 in the IP 3 -binding core have been proposed as potential candidate target sites for thimerosal [99] . These studies underpin the concept that thiol-modifying agents, like reactive oxygen species (ROS), may have differential effects on IP 3 R isoforms. Hence, differential IP 3 R-isoform expression may determine the cellular sensitivity towards oxidative stress. For instance, the expression of the IP 3 R3 isoform in bronchial epithelial cells might be part of a mechanism that allows this tissue to cope with its exposure to constitutive oxidative stress [96] , thereby avoiding cell death and tissue malfunction. The role of ROS in the IP 3 R regulation will be discussed in more detail in Section 5.
2.1.6. Regulation by phosphorylation IP 3 Rs are targets for numerous protein kinases including PKA, protein kinase B (PKB/Akt), protein kinase C, cGMP-dependent protein kinase, Ca 2+ -and CaM-dependent protein kinase II, cyclin-dependent kinases (CDK), mitogen-activated protein kinases (MAP kinases), polo-like kinases (PLK), Rho kinases, mammalian target of rapamycin (mTOR) and various protein tyrosine kinases (for reviews see [2, 100] ). We will focus in this review on those kinases for which a clear isoform-specific regulation has been demonstrated. IP 3 R1 is stoichiometrically phosphorylated by PKA at S1588 and S1755 (Fig. 1) , which are canonical PKA-substrate motifs [101] . The peripheral splice isoform S2 − was preferentially phosphorylated at the former site, while the neuronal isoform S2 + was phosphorylated at both sites, but mainly at the latter [101] . Contradictory functional effects were reported in earlier studies, probably reflecting the simultaneous presence of other IP 3 R isoforms [102] , the phosphorylation of other proteins involved in Ca 2+ handling or indirect regulation of PKA itself [100] . In DT40-TKO cells it was found, using alanine-substituted and phosphomimetic mutants, that phosphorylation of S1755 was necessary and sufficient for a marked activatory effect in the S2 + -splice variant, while both sites contributed to activation of the S2 − isoform [103, 104] . Single-channel analysis in lipid bilayers and whole-cell patch clamp of IP 3 R channels expressed in the plasma membrane [90] revealed that the primary effect of a phosphomimetic activation was an increase in the open probability at a subsaturating [IP 3 ], reflecting effects on the kinetics of the channel opening and closing [90] . The analysis of PKA phosphorylation of IP 3 R2 and IP 3 R3 was more difficult because consensus sites were absent in these isoforms [13] . Mutational analysis and controlled tryptic digestion revealed a unique PKA phosphorylation site in IP 3 R2 at S937 (Fig. 1) plays an important role in endocrine-cell responses to external stimuli [109] . PKB/Akt is a proto-oncogene involved in several cellular survival processes [110] . All three IP 3 R isoforms have the highly conserved phosphorylation motif RXRXX(S/T) in their C-terminus, and the phosphorylation at this site by PKB/Akt promoted survival (Fig. 1) [111, 112] . The modification was enhanced by the Ca 2+ -induced conformational change of the IP 3 R [113] , which may be a feedback mechanism to favor store refilling after Ca 2+ release. The anti-apoptotic effect of phosphorylation by PKB/Akt has been linked to inhibition of ER Ca 2+ release [112, 114] , as will be further discussed in Section 4.2.1. Several kinases that affect the cell cycle and cell proliferation can also regulate the IP 3 Rs in an isoform-dependent way. Their exact physiological role is however still unclear, as various kinases can target the same sites and as the phosphorylation sites involved have not all been identified. Moreover, during cell-cycle progression several kinases are simultaneously active, potentially leading to a more complex regulation of the IP 3 R. CDK1/cyclin B phosphorylates IP 3 R1 at S421 and T799, but neither of the two sites is conserved in IP 3 R2 and only the second one is conserved in IP 3 R3. CDK1/cyclin B-mediated phosphorylation of IP 3 R1 resulted in an increased IP 3 -binding and IICR activity [115, 116] .
The MAP kinases ERK1/2 can potentially recognize three sites present in mouse IP 3 R1 (S436, T945 and S1765) though not in IP 3 R2 or IP 3 R3. The phosphorylation of S436, located in a critical region of the IP 3 -binding core [117] , leads to an increased interaction between the suppressor domain and the IP 3 -binding core and to a decreased IP 3 binding and IICR in various cell types [118, 119] . In contrast to somatic tissues, ERK however appeared to stimulate IICR in oocytes, but this may be due to an indirect effect, e.g. by enhancing IP 3 R1 phosphorylation by another kinase [120, 121] . An interesting candidate for the latter is PLK1, which has in IP 3 R1 four potential phosphorylation sites (T1048, T1492, S1790 and T2656), two of them (T1492 and T2656) being conserved in the other isoforms. In vitro phosphorylation experiments supported a PLK1-mediated phosphorylation of T2656, and in addition demonstrated a significantly higher phosphorylation of IP 3 R3 compared to IP 3 R1 [122] .
A very interesting approach to investigate the IP 3 R1 phosphorylation sites implicated in cell-cycle control was taken by Machaca and collaborators, who performed a comprehensive phospho-peptide mapping of the endogenous IP 3 R1 during Xenopus laevis oocyte maturation [123] . This study covered nearly 75% of the cytosolic part of Xenopus IP 3 R1 and indicated a specific phosphorylation at T931, T1136 and S1145. All three sites are compatible with a site targeted by a MAP kinase or a CDK, but only the site encompassing T931 is highly conserved between species and corresponds to the above-mentioned T945 in mouse. Subsequent work expressing mutated IP 3 R1 in DT40 cells suggested that, similarly to what was found for S436 in somatic cells, its phosphorylation decreased both IP 3 binding and IICR [124] .
Regulation by other protein interactions
There is an increasing number of identified IP 3 R-interacting proteins (N60). This number includes not only regulatory proteins but also scaffolding proteins, protein kinases and phosphatases, structural proteins and motor proteins. An overview of all these interactions is beyond the scope of this review and is documented in several excellent reviews [2, 14, 15, 125, 126] . For many of these proteins the exact binding site is not known, and information about different isoforms is lacking (Table 1) . Moreover, the sequence information is not sufficient for predicting isoform-specific interactions. Only in a few cases a clear preference for a particular isoform has been documented [126] .
Differential expression of IP 3 R isoforms
The three IP 3 R isoforms have distinct but overlapping expression patterns, with most cell types expressing more than one subtype [2, 127] . A quantification of the relative expression levels using RT-PCR [128, 129] or using a combination of specific and common antibodies [46, [130] [131] [132] , yielded values for different cell types and tissues. A triangle-diagram representation of the relative mRNA-expression levels of the three IP 3 R isoforms obtained via RT-PCR is presented in Fig. 2 . While most cell types express two or even all three isoforms, there is often a predominant isoform, e.g. IP 3 R1 in neuronal cells, IP 3 R2 in liver and muscle cells and IP 3 R3 in most cultured cell types. It is also striking that primary cells (e.g. endothelial cells) switch to a higher proportion of the IP 3 R3 isoform after a few passages in culture [133] . IP 3 R-expression levels were indeed found to be modified during development and differentiation [127] . Promoter regions have been identified for IP 3 R1 [134] [135] [136] [137] , IP 3 R2 [138] and IP 3 R3 [139] , and it is evident that there are significant differences that could explain cell type-and differentiationdependent expression, but no general pattern is apparent. Numerous studies have shown a potential regulation of IP 3 R expression by factors such as retinoic acid, TGF-β and phorbol esters (as reviewed in [127] ). Many studies have shown that IP 3 R1 plays a crucial role in brain function (as reviewed in [15] ). Synaptic activity regulates the expression of IP 3 R1 in neurons depending on transcription and protein synthesis and requires PKA activity [140] . It was shown that TNFα regulates IP 3 R-mediated Ca 2+ responses in neurons via a JNK-dependent increase in IP 3 R-protein levels [141] . A promoter region encompassing a specificity protein-1 binding site was necessary for JNK-mediated regulation, pointing to a key pathway for the TNFα-induced modulation of IP 3 R1 in neurons [142] . Ca 2+ signal-transduction pathways are clearly involved in the regulation of IP 3 R1 [143, 144] . An example is the increased Most cell types express more than one or all three IP 3 R isoforms. In many cases there seems to be a preference, e.g. IP 3 R1 in cerebellum and neurons, IP 3 R2 in liver, and IP 3 R3 in many cultured cell types. The relative expression levels of the three isoforms were obtained by a RT-PCR method as described previously [128, 129] . Data obtained from RT-PCR were previously compared with determinations of the three IP 3 R isoforms at the protein level using isoform-specific antibodies, and were found to be in good agreement [130] . The values on the diagram represent the percentage of each isoform in a particular cell type and can be read on the respective axis.
expression of the IP 3 R in smooth muscle, which was associated with hypertension and required activation of the calcineurin-nuclear factor of activated T cells axis [145] . It was also found that dopamine receptors regulate IP 3 R1 expression via activator protein 1 and nuclear factor of activated T cells mediated transcription [146] [147] [148] . IP 3 R2 and IP 3 R3 double-KO mice showed severe impairment of salivation. This indicates that IP 3 R2 and IP 3 R3 are the major Ca 2+ -release channels involved in digestive enzyme secretion and possibly in secretory processes of other exocrine tissues [149] . Moreover, analysis of the double-KO mice also revealed a role for these isoforms in the differentiation of granular cell precursors [150] .
In line with the observation that IP 3 R3 was preferentially expressed in cultured cells [129, 133] , a link between IP 3 R3 expression and cell proliferation was also found in the estrogen-dependent MCF-7 breastcancer cell line [151] . Higher IP 3 R3 levels in these cells did not lead to increased apoptosis as found in other studies [152] . ] rise in the cytosol and the mitochondria, thereby resulting in a decreased apoptotic sensitivity to stimuli that act through Ca 2+ signaling, like menadione.
As discussed in Pierro et al. [154] , these observations correlate well with a micro-array analysis of a variety of isogenic K-RAS-deficient cell lines, showing an increase in IP 3 R3 mRNA-expression levels. Furthermore, also earlier reports have linked alterations in K-RAS expression to changes in IP 3 R-isoform expression. For instance, ITPR2, the gene encoding for IP 3 R2, seems to be co-amplified with KRAS2 amplification in non-small cell lung carcinoma [155] . The expression of IP 3 R isoforms can also be regulated at a posttranscriptional level by specific degradation, which occurs for the three isoforms with different kinetics [130] . Moreover, it was recently reported that the translation of the IP 3 R2 messenger was regulated by the muscle-specific miRNA-133a [156] . The mutual antagonism between IP 3 R2 and miRNA-133a was found to regulate Ca 2+ signals and cardiac hypertrophy. Thereby, hypertrophic stimuli that engaged IICR lead to a decrease in miRNA-133a levels and subsequently a further augmentation of IP 3 R2 levels and therefore pro-hypertrophic Ca 2+ release [156] . This mechanism is specific for IP 3 R2 in the heart, but it is conceivable that similar mechanisms involving miRNAs may be operative for IP 3 R1 and IP 3 R3 as well. IP 3 Rs are most abundantly expressed in the ER but they are also found in the nuclear envelope, Golgi apparatus, secretory vesicles and plasma membrane (as reviewed in [127] ). Even within the ER there is no uniform distribution of IP 3 Rs [157, 158] . The compartmentalization and formation of microdomains of Ca 2+ signaling have been recognized as very important for specific cell functions as e.g. in pancreatic acinar cells [159, 160] . Of particular relevance for the present review is the close apposition between the ER and mitochondrial membranes (the mitochondria-associated ER membranes, MAMs) with a key role for IP 3 Rs to mediate specific ER-to-mitochondria Ca 2+ transfer [161, 162] .
The IP 3 R contributes at the MAMs to the physical link between the ER and the mitochondria as the cytosolic chaperone glucose-regulated protein 75 was found to tether the N-terminal domain of IP 3 R1 to the mitochondria-located voltage-dependent anion channel 1 [163] . IP 3 R3 was found in CHO cells to co-localize more closely with the mitochondria and to preferentially transmit Ca 2+ signals to these organelles [152, 164] . The importance of these microdomains for cell fate and the role of particular IP 3 R isoforms will be further discussed in Sections 3 and 4. can be released by the IP 3 R after cell stimulation. As the IP 3 R is a part of the protein complex in the MAMs, the increased IP 3 R activity can easily lead to mitochondrial Ca 2+ overload (for review, see [165] ). The subsequent mitochondrial outer-membrane permeabilization, generally considered as a point-of-no-return to cell death, will lead to the release of pro-apoptotic factors like e.g. cytochrome C [166] .
] ER is therefore protective against apoptosis, but too low levels lead to the accumulation of misfolded proteins in the ER, resulting in ER stress, and the cells develop the so-called unfolded protein response (UPR) [167, 168] . Classical mediators of the UPR are the ER-stress sensors inositolrequiring enzyme 1α (IRE1α), protein kinase RNA-like ER kinase (PERK), and activating transcription factor 6 (ATF6) [169] . The UPR can lead to autophagy, as part of the pathway to restore cell homeostasis, or to apoptosis if the homeostasis cannot be recovered [170] [171] [172] [173] . Independently of the UPR, if for any reason Ca 2+ transfer from the ER to the mitochondria drops below a threshold value, energy production by the mitochondria is not guaranteed anymore and autophagy also follows [174] . Finally, high levels of Ca 2+ release into the cytosol generally will be associated with mitochondrial Ca 2+ overload and the opening of the mitochondrial permeability transition pore [175, 176] , leading to a variety of cell-death modalities, including apoptosis and necrosis [177] . -leak channel "en route" from the ER to the plasma membrane [183] . We will focus here on the most documented Ca 2+ -leak mechanisms proposed to be involved in cell-fate regulation.
IP 3 Rs
Although the IP 3 R does not display a significant activity in the absence of cytosolic IP 3 [2] , the IP 3 concentration present under nonstimulated conditions can be sufficient to allow this channel to set up the leakage of Ca 2+ out of the ER [188] . Moreover, the IP 3 R can be sensitized to basal IP 3 levels by regulatory mechanisms including phosphorylation [189] and interaction with other proteins [190, 191] leading to (partial) depletion of the ER. Finally during apoptosis the active caspase 3 can cleave the IP 3 R1 (but probably not the other isoforms) just downstream of the 1888DEVD consensus site [192] . The remaining membrane-inserted C-terminal part of the IP 3 R is responsible for an IP 3 -independent Ca 2+ release out of the ER [193, 194] . The role of this cleavage in apoptosis is still a matter of debate as will be further discussed below (Section 4.1.1) [195, 196] . Recently, IP 3 R1 also emerged as a substrate of calpains, resulting in the accumulation of a stable proteolytic fragment of~95 kDa [197] . Amino acid sequencing of the N-terminus of this fragment elucidated a specific calpain-cleavage site between residues 1917 and 1918 of the rat IP 3 R1 conserved among mouse and human IP 3 R1, which does not seem to be present in IP 3 R2 or IP 3 R3 channels. Strikingly, this calpain-cleavage site is located in the close proximity of the caspase 3-cleavage site (Fig. 3) . ] cyt [197] .
Bcl-2-family members
Bcl-2 itself as well as the related Bcl-Xl are prototypical antiapoptotic proteins inhibiting apoptosis primarily by interacting with the pro-apoptotic family members [198] . In addition, other functions have been described [199, 200] . In particular, these proteins have the ability to form ion pores in synthetic membranes [201, 202] . Subsequently, it was shown that they decreased the ER Ca 2+ content and were proposed to form a Ca
2+
-leak in the ER [203, 204] . However, overexpression of Bcl-2 did not lead to a decreased ER Ca 2+ content in all studies (as reviewed in [205] -handling proteins. First, Bcl-2 can directly or indirectly interact with SERCA pumps [207] . More recent data indicated that Bcl-2 is capable to inactivate SERCA [208] . This inactivation can be counteracted by heat-shock proteins like HSP70 [209] . Second, both Bcl-2 and Bcl-Xl can also directly interact with the IP 3 R as will be discussed in detail below (Section 4.2.2). Bcl-2 proteins have been implicated in the regulation of the PKA-dependent phosphorylation state of IP 3 R1 channels [189] . With the rise in the ratio of anti-apoptotic over pro-apoptotic Bcl-2 proteins more binding of Bcl-2 to IP 3 Rs was observed, which resulted in an enhanced PKA-dependent phosphorylation of IP 3 R1. This led to a hypersensitization of IP 3 Rs to basal IP 3 [216] [217] [218] [219] . The founding member of this family, a small (26 kDa) protein, called BI-1 (TMBIM6), was identified in a high-copy Bax-suppressor screen in yeast [216] . Recently, BI-1 has been settled to be a 6-transmembrane domain protein, which strongly resembles the hydrophobicity profile of the other TMBIM-family members [219] . Consistent with its ER localization, BI-1 was shown to protect against ER stress-induced cell death in mammalian cells [220] . BI-1 was proposed to have a role in decreasing the [Ca 2+ ] ER downstream of Bcl-Xl [215] . This Ca
-leak function of BI-1 can be explained by several mechanisms. BI-1 could act as a pH-sensitive Ca 2+ -leak channel in the ER, whereby the C-terminal part of the protein dipping into the membrane would be crucial [221] [222] [223] . Alternatively, a Ca 2+ /H + -antiporter mechanism has been proposed [224] .
In addition, BI-1 also binds and sensitizes IP 3 Rs through an interaction between the C-terminal channel domains of both proteins. Ca -channel-pore-dead mutant of BI-1 remains capable of sensitizing IP 3 Rs [191] . Although binding of BI-1 has only been demonstrated for IP 3 R1, it is likely that also other isoforms are targeted by BI-1, since IP 3 R sensitization by BI-1 was observed in MEF cells, which express high levels of IP 3 R3. It has been reported that BI-1 increases basal autophagy via promoting Ca 2+ flux through IP 3 Rs, thereby decreasing the amount of Ca 2+ available for transfer from the ER to the mitochondria, subsequently resulting in activation of AMPK and triggering autophagic flux [174, [225] [226] [227] . These findings seem to be in contrast with another report demonstrating that BI-1-knock-out cells displayed increased autophagic flux [228] . Yet, this could implicate that BI-1 could function as a rheostat controlling basal autophagic flux.
Using in vitro (cell lines) and in vivo (Drosophila melanogaster and zebrafish) models of ER stress-induced apoptosis, it was shown that during ER stress glutamate receptor, ionotropic NMDA-associated protein 1 (GRINA/TMBIM3), another BI-1-family member, is upregulated in a PERK-dependent manner. GRINA also interacts with IP 3 R1 and IP 3 R3, forming a complex and cooperating with BI-1 during ER stress (Fig. 3) . GRINA suppresses the depletion of the ER Ca 2+ stores and thereby prevents ER stress-induced apoptosis [229] . This revealed a critical and dynamic role for GRINA in suppressing ER stress by acting as an IP 3 R inhibitor [229] . BI-1 may prevent IP 3 R inhibition by GRINA by forming a complex in healthy, non-stressed cells and may further support viability by sensitizing IP 3 R function, subtly lowering the [Ca
] ER and increasing basal autophagy. Golgi anti-apoptotic protein (GAAP/TMBIM4) is another TMBIMfamily member that has been proposed to bind and regulate IP 3 Rs (Fig. 3) . The topology of this protein that is conserved among all eukaryotes and is present even in some poxviruses, showed a 6-transmembrane domain profile, which could serve as a model for other TMBIM-family members [220] . Its anti-apoptotic properties have been linked to altered intracellular Ca 2+ dynamics at the level of the plasma membrane and at the level of the ER. Human GAAP overexpression in U2OS cells, which mainly express IP 3 R3, suppressed agonist-induced IP 3 R-mediated Ca 2+ release by reducing the sensitivity of IP 3 Rs to IP 3 [230] . At the molecular level, hGAAP co-immunoprecipitated with IP 3 R3, indicating that endogenous IP 3 R3/hGAAP-protein complexes are present in a cellular context.
Translocon
The translocon or SEC61 complex is a specific protein complex forming a channel through the ER membrane needed for the translocation of polypeptides during protein translation. In its completely open state, e.g. after puromycin treatment, it can also allow the transfer of Ca 2+ out of the ER [231, 232] . However, as can be expected for maintaining cell survival, the closed state predominates [233] suggesting the presence of regulatory mechanisms. Ca 2+ transfer through the translocon appears to be inhibited by CaM [234] as well as by the glucose-regulated protein 78/immunoglobulin heavy chain-binding protein (GRP78/BiP) [235, 236] . During ER stress, the binding of the luminal ER protein GRP78/BiP to unfolded or misfolded proteins releases the translocon from this inhibition. The increased Ca 2+ leak from the ER will thereby contribute to the further development of the UPR [237] and/or to the eventual demise of the cell [236] .
Presenilins
Presenilins 1 and 2 are intramembrane-cleaving proteases containing 9 transmembrane domains and having a cytosolic N-terminus and a very short C-terminus [238] . Both of them can form the catalytical unit of the γ-secretase complex which is responsible for the generation of the amyloid-β peptides related to Alzheimer's disease [238] [239] [240] . Presenilins can be expressed at the ER and according to some recent studies especially at the MAMs, where they can modulate the connection between the ER and the mitochondria [241] [242] [243] . Interestingly, multiple, non-exclusive, roles for presenilins in ER Ca 2+ handling have been described. Presenilins were proposed to directly form a Ca 2+ -leak channel [244, 245] . Despite the controversy [246] , a recent unbiased siRNA screen confirmed that at least presenilin 2 acts as a Ca 2+ -leak channel [183] . Presenilins can however also affect Ca 2+ handling by other mechanisms. Mutated forms of presenilins can stimulate the activity [247] [248] [249] [250] [251] [252] or modulate the expression levels of the IP 3 R [253] or the RyR [254] [255] [256] [257] [258] as well as regulate SERCA pumps [259] . Presenilins may also affect store-operated Ca 2+ entry in the cell, which may be related to the [Ca 2+ ] ER [240] , or modulate lysosomal Ca 2+ homeostasis [260] .
Regulation of IP 3 R isoforms by luminal ER proteins
With respect to cell fate, the regulation of the IP 3 Rs by a number of luminal ER proteins appears important [167] . These regulatory mechanisms display IP 3 R-isoform specificity. Fig. 3 . Differential regulation of the IP 3 R isoforms by various pro-and anti-apoptotic proteins. The three isoforms of the IP 3 R, located at the ER membrane, are shown with their cytosolic N-and C-termini and the six transmembrane domains (panels A, B and C). The binding sites for the various cell-fate regulators are indicated. The anti-and the proapoptotic proteins are presented in green and in red, respectively. The three isoforms are targeted by Bcl-2-family anti-apoptotic members, since Bcl-2 and Bcl-Xl bind to the modulatory domain, regulating receptor activity, and together with Mcl-1 to the C-terminus of the IP 3 Rs. GIT1 and GIT2 have two different binding sites in the C-terminal domain of type-1, -2, and -3 receptors and their binding leads to suppression of IICR. All the isoforms are phosphorylated and inhibited by PKB/Akt and targeted sites are indicated. Many interactions were observed only for a specific isoform. (A) Beclin 1 is recruited to the N-terminus of IP 3 R1, leading to a suppression of autophagy. IP 3 R1 is a target of calpain and caspase 3, but binding of Bok could prevent caspase 3-dependent cleavage. GRINA is another BI-1-family member, besides BI-1 itself, that binds to IP 3 R1. Cytochrome-C interaction with the C-terminus causes pro-apoptotic Ca 2+ release. 
GRP78/BiP
Under normal, unstressed conditions GRP78/BiP binds specifically to IP 3 R1 by interacting with the variable part (residues 2463-2528) of its luminal loop, located between transmembrane domains 5 and 6 (Fig. 3) [61] . GRP78/BiP stabilizes the IP 3 R1 and thus allows a higher level of IICR. During ER stress, GRP78/BiP dissociates from the IP 3 R1 to bind to unfolded or misfolded proteins leading to a decreased Ca 2+ release through the IP 3 R1, which protects the ER from further depletion. Therefore the IP 3 R1 can be considered as a fourth ER-stress sensor, in addition to the classical ER-stress sensors IRE1α, PERK, and ATF6 [185] . GRP78/BiP also interacts with the sigma-1 receptor, thereby inhibiting its function. During ER stress, the sigma-1 receptor is released from GRP78/BiP, and acts to stabilize IP 3 R3 at the MAMs (Fig. 3) [261] . This in turn promotes Ca 2+ transfer to the mitochondria and favors cell survival.
Endoplasmic-reticulum resident protein 44 (ERp44)
ERp44 is a protein of the thioredoxin family which also specifically binds to IP 3 R1, targeting the same variable part of the luminal loop as GRP78/BiP (Fig. 3) [62] . Both proteins thus compete for the same region, but in contrast to GRP78/BiP, ERp44 inhibits the IP 3 R1. During ER stress, GRP78/BiP dissociates from IP 3 R1, while binding of the upregulated ERp44 is increased, leading to a further inhibition of the IP 3 R1 and a protection of the ER against further Ca 2+ depletion [262] . 
ER oxidase 1α (ERO1α)
ERO1α is a major catalyst of oxidative folding that can interact with ERp44 [262] . During ER stress, ERO1α is upregulated, leading simultaneously to the retention of ERp44 as well as to ER hyperoxidation. Consequently the interaction between ERp44 and IP 3 Rs is disrupted (Fig. 3) The requirement of IP 3 Rs for the execution of apoptosis has been observed in many experimental and cellular paradigms [194, 265, 266] , but the mechanisms remain poorly understood. During the last decade, evidence emerged for a positive feedback loop between IP 3 Rs and caspase 3, the executioner caspase in apoptosis [194] . An extensive study on the degradation of the three isoforms upon TNFα treatment associated the subsequent apoptosis with caspase-dependent degradation of IP 3 R1 and IP 3 R2, but not of IP 3 R3 channels [267] . A consensus sequence, DEVD, for caspase-3 cleavage was identified in the primary sequence of the IP 3 R1 of mouse, rat and human origin [192] (see Section 3.1.1). Consistent with these in silico findings, both intrinsic and extrinsic apoptosis inducers led in Jurkat cells to the cleavage of IP 3 R1 (Fig. 3) , but not of IP 3 R2 or IP 3 R3, as an early event. This proteolytic cleavage resulted in the generation of a relatively stable C-terminal IP 3 R fragment of about 90 kDa (IP 3 R1
Δ1−1889
), consistent with the position of the DEVD sequence in the full-length IP 3 R1 sequence (e.g. 1889DEVD in mouse, 1888DEVD in rat and 1835DEVD in human protein). The fragment is localized in the ER membrane and contains all six transmembrane domains and the Ca 2+ channel-pore domain of IP 3 R1 [194, 268] . This specific caspase 3-mediated IP 3 R1 cleavage clearly preceded the general decline of all IP 3 R isoforms in the later stages of apoptosis induction. Consistent with the decrease in IP 3 R1 levels, recombinant caspase 3 attenuated IICR from mouse cerebellar microsomes. Mutant IP 3 R1 channels resistant to caspase-3 cleavage due to a D1889I change (IP 3 R1 Δcasp3 ) expressed in DT40-TKO cells were used to gain more mechanistic insights [194] . Strikingly, while IP 3 R1-expressing cells displayed increased sensitivity towards apoptosis inducers, IP 3 R1
Δcasp3 -expressing cells were equally resistant to these cell-death treatments as mock DT40-TKO cells. Both caspase-3 activation and apoptosis did not strictly require IICR, since DT40-TKO cells expressing an N-terminally deleted IP 3 R1 (IP 3 R1
Δ1−225
) unable to mediate IICR, were equally susceptible to apoptotic stimuli and were equally potent in activating caspase 3. While IICR was dispensable for apoptosis execution, caspase-3 activation and apoptosis execution clearly required Ca 2+ release via a mechanism involving the production or the presence of IP 3 R1 Δ1−1889 [194] . These observations are consistent with findings in IP 3 R-deficient T cells, which are also impaired in caspase-3 activation [269] . An apoptotic stimulus appeared to be required in IP 3 R1
Δ1−1889
-expressing cells to trigger cell death and ER Ca 2+ -store depletion [195] . The C-terminal IP 3 R1 fragment slightly enhanced the Ca 2+ leak from the ER [195] , supporting the concept that the large regulatory domain of the IP 3 R1 is necessary to keep the C-terminal channel domain in a closed state [193] . The extent of ER Ca
2+
-store depletion differed from no effect or only a minor effect [195, 270] to a strong effect on the [Ca 2+ ] ER [193] . Moreover, the C-terminal channel fragment may also interact with plasmalemmal components that mediate Ca 2 + influx from the extracellular environment. oscillations [195] . Recently, the relevance of IP 3 R1 truncation by caspase 3 for the execution of apoptosis has been questioned. It was reported that although the proteolytic cleavage of IP 3 R1 by caspase 3 described in lymphoid cells was also shown in neuronal cells [272] , it did not occur in a variety of other cell models, including HEK293 and HeLa cells [273] . Moreover, IP 3 R1 was shown to be a poor substrate of caspase 3 in in vitro proteolysis experiments and its cleavage was observed after the cleavage of poly(ADP-ribose) polymerase (PARP), a hallmark of apoptosis [196] . Finally, the staurosporine-induced [Ca 2+ ] cyt rise during the initiation of apoptosis was independent of the presence or activation of caspase 3 [273] . In contrast, apoptosis seemed to depend on the induction of IP 3 signaling, since an IP 3 sponge was able to attenuate the staurosporineinduced [Ca 2+ ] cyt rise and cell death. Hence, these reports seem to advocate that caspase 3-mediated IP 3 R1 truncation may not be a proximal event and/or a driving mechanism in apoptosis execution but rather a distal event resulting from on-going apoptosis [273] .
Finally, a recent study by Yule and co-workers showed that during apoptosis multiple proteolytic cleavage events occur, generating Nand C-terminal IP 3 R fragments, but that these remain associated at the ER membranes into tetrameric IP 3 R channels [270] . This was also found for IP 3 R2 channels, for which recombinantly generated N-and C-termini that do not occur in apoptotic cells could constitute channel activity.
Calpain
Calpains are a class of cysteine proteases, directly activated by intracellular Ca 2+ . Highly selective calpain-mediated degradation of IP 3 R was observed [274] and originally, it has been proposed that in TNFα-induced apoptosis in T-cell lymphoma cells, the activation of calpains leads to the degradation of IP 3 R3 channels, while IP 3 R1 and IP 3 R2 channels were degraded by caspases [267] . Later, as described above (Section 3.1.1), IP 3 R1 was also found to be a substrate of calpains ( Fig. 3) , resulting in the accumulation of a stable proteolytic fragment of~95 kDa, which was toxic to cells when recombinantly expressed [197] . Neumar and co-workers generated an antibody that specifically recognizes the calpain-cleaved IP 3 R1 fragment but not the full-length IP 3 R1 protein (Ab2054) [197] . Using this antibody, it was shown that cardiac arrest leads to the activation of calpains and subsequent cleavage of IP 3 R1 in vivo in the Purkinje cells of the cerebellum, which were associated with increased neurodegeneration of the Purkinje cells. Overexpression of the calpain-cleaved IP 3 R1 product in primary cortical neurons resulted in a reduced neuronal viability in a limited subset of neurons [275] . This was associated with impaired ER Ca
2+
-buffering properties of these cells, resulting in increased glutamate-induced [Ca 2+ ] cyt rises and increased susceptibility to glutamate-induced excitotoxicity of these neurons. Again, these observations seem in line with results obtained for the caspase 3-cleaved IP 3 R1 fragment, showing that expression of this C-terminal channel fragment is not sufficient to cause cell death, but rather may act as a co-incidence detector in cells exposed to cell-death stimuli or cytotoxic conditions. Furthermore, also during calpain-mediated cleavage of IP 3 R1, Nand C-terminal fragments may remain associated to form functional IP 3 R channels [270] .
Cytochrome C
Cytochrome C is released from the mitochondria upon mitochondrial outer-membrane permeabilization and is a critical factor for apoptosis induction. Boehning and co-workers found that cytochrome C translocates to the ER upon apoptosis induction, where it binds to IP 3 R1 and IP 3 R3 (Fig. 3) [276] . The expression of IP 3 R2 in the cell models used (PC12 cells and HeLa cells) was too low to draw any conclusions about possible binding of cytochrome C to this isoform. This ER translocation of cytochrome C was independent of downstream caspase-3 activation but required the presence of the IP 3 R, since DT40-TKO cells failed to recruit cytochrome C to the ER membranes. Cytochrome C binding to IP 3 R1 abolished the bell-shaped dependent regulation of the channel by the [Ca 2+ ] cyt , thereby preventing the inhibition of ] cyt higher than 1 μM. In intact cells exposed to staurosporine, the translocation of cytochrome C to the IP 3 R was associated with a sustained increase in [Ca 2+ ] cyt . Furthermore, in staurosporine-treated cells, the release of cytochrome C from the mitochondria seemed to be triggered by cytosolic Ca 2+ spikes, which could be prevented by the Ca 2+ chelator BAPTA-AM. Exogenous expression of the C-terminal tail of IP 3 R1, which contains the cytochrome C-binding site, suppressed the increase in Ca 2+ spiking and sustained elevation of [Ca 2+ ] cyt in response to staurosporine without interfering with cytochrome C's ability to activate caspase 3. Thus, this study shows an intimate link between mitochondrial cytochrome-C release and ER Ca 2+ release as a feed-forward mechanism for apoptosis induction [277] . Further molecular studies revealed a 16-a.a. sequence (2621DNK TVTFEEHIKEEHN2636) in the C-terminal tail of IP 3 R1 as the cytochrome C-binding site (IP 3 RCYT) [278] . The four glutamate residues seemed important for cytochrome-C binding, but yet the third glutamate residue (E2633) is not conserved among IP 3 R2 or IP 3 R3, although cytochrome C also has been suggested to bind to IP 3 R3. A cell-permeable version of this peptide inhibited caspase-3 activity and subsequent cell death upon the induction of either intrinsic or extrinsic apoptosis pathways. The feedback of cytochrome C on IP 3 Rs through binding to this C-terminal site has been confirmed in independent studies [279, 280] in which electroporation of cytochrome C in C6 glioma cells triggered apoptotic cell death that could be partially counteracted by co-electroporating the IP 3 RCYT peptide.
Finally, detailed kinetic studies revealed that the extrinsic Fasinduced apoptosis required a biphasic Ca 2 + release from the ER [281] . The rapid release of Ca 2 + was caused by the activation of IP 3 Rs by IP 3 produced from phospholipase Cγ (PLCγ), whereas the slower, sustained release of Ca 2 + was due to the release of cytochrome C from the mitochondria and binding of cytochrome C to the IP 3 R. Both processes were required to effectively induce Fas-mediated apoptosis.
Bok
Bok is a ubiquitously expressed multi-domain pro-apoptotic Bcl-2-family member that resembles Bak and Bax. Consequently, cellular overexpression of Bok results in apoptosis [282] in a Bak/Baxdependent manner [283] . Despite the fact that Bok is widely expressed, particularly in B-lymphoid cells, while many other human cancers are Bok deficient, BOK −/− mice did neither display an increased lymphoma development upon c-myc overexpression under the control of immunoglobulin heavy chain enhancer, nor any other major phenotypic issue [284] . On the other hand, Bok overexpression resulted in a fragmentation of the ER, the Golgi apparatus and Golgi-derived compartments, consistent with its presence not only at the mitochondria but also at these intracellular compartments [283] . The targeting of Bok to these ER/Golgi compartments occurs via its C-terminal transmembrane domain, which is both necessary and sufficient. Interestingly, cells lacking Bok were slightly more sensitive to Golgi-fragmentation inducers like brefeldin A and/or ER-stress inducers like tunicamycin, but not to apoptosis inducers like etoposide and staurosporine, whereas Bak/ Bax-deficient cells generally were resistant to all these treatments. This may be due to a defective ER-stress response caused by impaired IRE1α activation, and to increased pro-apoptotic signaling caused by increased JNK activation and Bim upregulation in Bokdeficient cells. Recent evidence has emerged that Bok binds to IP 3 Rs and controls their proteolytic degradation [214] . This finding is consistent with the proposed role of Bok upstream of Bak/Bax [283] and with the failure of Bok to directly associate with any of the Bcl-2-family members. Strikingly, IP 3 Rs seem to serve as the major cellular harbor for Bok by a strong, constitutive interaction. Although all three IP 3 R isoforms can interact with Bok, preferential binding partners of Bok are IP 3 R1 and IP 3 R2 (Fig. 3) . At the molecular level, Bok binds to IP 3 Rs via its Nterminal Bcl-2 homology 4 domain (BH4) to a highly charged region of the IP 3 R1 covering residues 1895-1903 (a.a. sequence PSRKKAKEP) located in the cytosolic regulatory domain of the IP 3 R. This sequence was strongly conserved among IP 3 R1 proteins from different species and not conserved among other IP 3 R isoforms. It was proposed that a sequence with a similar charge distribution is present in IP 3 R2 (PRMRVRDS), which is also conserved among different species. Bok binding to IP 3 R1 seemed to control its degradation. It is well established that stimulated cells down-regulate IP 3 Rs via a process that involves poly-ubiquitination and proteasomal degradation [285, 286] . Cells exposed to chronic IP 3 R activation showed a concomitant decline in both Bok and IP 3 R levels, whereas other Bcl-2-family members remained unaltered. Thus, it seems that IP 3 R/Bok complexes are degraded as a "combined unit" [214] . In in vitro cleavage experiments, it appeared that IP 3 Rs from Bok −/− cells were more susceptible to cleavage by chymotrypsin. This was consistent with in cellulo experiments demonstrating that caspase 3-mediated cleavage of IP 3 R1 was more readily observed in Bok −/− cells than in wild-type cells upon exposure to staurosporine. Although wild-type MEF and Bok −/− MEF cells display very similar IICR properties, it has to be noted that differences in overall IP 3 R-expression levels between both cell lines could complicate such an analysis. In any case, the recruitment of Bok to the IP 3 R and concomitant interference with its proteolytic cleavage during apoptosis is very intriguing and could be a novel mechanism by which IP 3 R levels are regulated during apoptosis. These findings might also have implications for human cancers, since high-resolution analyses of somatic copynumber alterations from more than 3000 cancer specimens revealed the loss of Bok as a significant alteration [287] .
4.2. Anti-apoptotic/pro-survival proteins 4.2.1. PKB/Akt-signaling cascade As discussed in Section 2.1.6, PKB/Akt, a known pro-survival factor that is activated by phosphatidylinositol 3,4,5-trisphosphate [288] , phosphorylates all three IP 3 R isoforms in normal, dividing cells (Fig. 3) . This process is stimulated by growth factors [111, 112] . For IP 3 R1, phosphorylation by PKB/Akt occurred at S2681, although IP 3 Rs defective in undergoing PKB/Akt phosphorylation or mimicking constitutive PKB/Akt phosphorylation displayed similar IICR properties [111] . Yet, follow-up work revealed that PKB-mediated phosphorylation of IP 3 R1 dictated the cellular susceptibility to apoptotic stimuli with phospho-dead IP 3 R1 S2681A -expressing cells being more sensitive to cell death than phospho-mimetic IP 3 R1 S2681E -expressing cells [112] . The role of PKB/Akt in suppressing "toxic" IP 3 R activity has been related to IP 3 R3 [289] . PKB/Akt was much more potent in protecting cells expressing high IP 3 R3 levels (like COS cells) than cells expressing high IP 3 R1 levels (like SH-SY5Y cells). While PKB/Akt poorly protected native SH-SY5Y cells against arachidonic acid-induced apoptosis, it became very effective to protect SH-SY5Y cells ectopically expressing IP 3 R3. Moreover, the phosphorylation of IP 3 Rs by PKB/Akt may also depend on the cellular context, including the [Ca 2+ ] cyt . For instance, IP 3 R phosphorylation by PKB/Akt was shown to be stimulated in the presence of Ca 2+ . As stated above (Section 2.1.5), the mechanism may involve Ca 2+ -dependent changes in IP 3 R conformation, thereby enhancing complex formation between IP 3 Rs and PKB/Akt and/or by increasing the accessibility of the PKB-phosphorylation site of the IP 3 R [113] .
Further studies revealed that the complex between IP 3 R3 and PKB/Akt is regulated by protein phosphatase 2A (PP2A) and by the tumor suppressor promyelocytic-leukemia (PML) protein [290, 291] . The latter promotes the recruitment of PP2A to the IP 3 R3, thereby counteracting PKB/Akt activity and suppressing PKB/Akt-mediated phosphorylation of IP 3 R3. The PKB/Akt-phosphorylation status and pro-apoptotic properties of the IP 3 R3 might be dynamically regulated and influenced by the PML status of the cell, since in the presence of PML, IP 3 R3 mediates Ca 2+ flux into the mitochondria and thus apoptosis will be promoted.
Altered or lost PML function and expression due to genomic translocations or mutations, as it has been observed in a large number of human cancers including hematological malignancies and solid tumors (as reviewed in [292] ), could compromise the pro-apoptotic Ca 2+ signaling through suppressed IP 3 R3 function and suppressed ERmitochondrial Ca 2+ transfer. This mechanism may therefore contribute to the oncogenic properties of PML-deficient cancer cells [293, 294] . Phosphatase and tensin homolog deleted on chromosome 10 (PTEN) is very well known as a negative regulator of PKB/Akt signaling by acting as a lipid phosphatase counteracting the accumulation of the lipid second messenger phosphatidylinositol 3,4,5-trisphosphate and thereby preventing the phosphorylation and activation of PKB/Akt [295, 296] . Evidence has now emerged that PTEN at the MAMs can directly reduce IP 3 R3 phosphorylation by PKB/Akt by a proteinphosphatase activity, thereby promoting Ca 2+ transfer to the mitochondria [297] . In addition to this, ER-localized PTEN may also increase the tethering between the ER and the mitochondria.
Anti-apoptotic Bcl-2-family members
Anti-apoptotic Bcl-2-family members, including Bcl-2, Bcl-Xl and Mcl-1, have been implicated in binding to and regulating IP 3 R channels (Fig. 3) [205, 298] . Bcl-2 was shown to form endogenous complexes with all three IP 3 R isoforms and its overexpression in immature T cells with very low endogenous Bcl-2 levels, resulted in a reduced anti-CD3-induced IICR [299] . In follow-up work, it became clear that the IP 3 R-inhibitory properties of Bcl-2 were dependent on the strength of the T cell-receptor activation [300] . Bcl-2 mainly inhibited global Ca 2+ transients provoked by high concentrations of anti-CD3 and therefore strong T cell-receptor activation, associated with pro-apoptotic Ca 2+ -signaling events, but not Ca 2+ oscillations triggered by low concentrations of anti-CD3 and thus weak T cell-receptor activation, associated with pro-survival Ca 2+ -signaling events. A detailed molecular study revealed a 20 a.a. sequence in the center of the regulatory domain of the IP 3 R (a.a. 1389-1408 of mouse IP 3 R1) as the target for antiapoptotic Bcl-2 [301] . An IP 3 R1-derived peptide (IDP) covering this site could disrupt endogenous IP 3 R/Bcl-2-protein complexes. As a consequence, a cell-permeable version of this peptide (TAT-IDP) reversed Bcl-2's inhibitory action on the IP 3 R, thereby promoting IICR and subsequent apoptotic cell death induced by high concentrations of anti-CD3 in T cells. Sequence analysis of IDP revealed that it is conserved among the various IP 3 R isoforms in different species, correlating with the original observations that Bcl-2 can form endogenous complexes with all three IP 3 R isoforms [279, 299] . The BH4 domain (a.a. 6-30) of Bcl-2 was found to be necessary and sufficient for binding to and inhibiting IP 3 Rs [302] . A synthetic BH4-domain peptide could interact with the central, modulatory domain of all three IP 3 R isoforms thereby suppressing IICR and apoptosis. Further structural studies in which the α-helical structure of the BH4-Bcl-2 peptide was disrupted by mutating backbone residues into G, revealed the critical role of the alpha-helical properties of this domain for binding and inhibiting IP 3 Rs, and for protecting against Ca 2+ -dependent apoptotic stimuli like staurosporine [303] . In addition, the BH4 domain of Bcl-Xl failed to bind and inhibit IP 3 Rs [279] , which might be attributed to a single amino acid difference between both domains. A single amino acid change of K17 into D in BH4-Bcl-2, thereby mimicking BH4-Bcl-Xl, was sufficient to abolish its ability to bind and inhibit IP 3 Rs. In contrast, mutating D11 into K in BH4-Bcl-Xl, thereby mimicking BH4-Bcl-2, induced IP 3 R binding and inhibition. Hence, it seems that electrostatic interactions are critical for complex formation between IP 3 Rs and the BH4 domain of Bcl-2 [304] . This has important biological consequences for the anti-apoptotic properties of Bcl-2 and Bcl-Xl, suggesting distinct cellular targets for their BH4 domains [279] . Nevertheless, it should be pointed out that although Bcl-2 and Bcl-Xl seem to differ at the level of their BH4 domain, full-size Bcl-Xl was able to bind to the modulatory domain of IP 3 R1, but with a lower affinity than the full-size Bcl-2 [305] . These fundamental insights in IP 3 R/Bcl-2-complex formation and peptide tools that target the BH4 domain of Bcl-2 but not that of Bcl-Xl have been exploited to trigger pro-apoptotic Ca 2+ signaling in Bcl-2-dependent cancer cells, like chronic lymphocytic leukemia [306] and diffuse large B-cell lymphoma [307] . A stabilized, protease-resistant version of the cell-permeable TAT-IDP (TAT-IDP S ) seemed very effective to trigger apoptosis in primary cells obtained from chronic lymphocytic leukemia patients but not in lymphocytes isolated from healthy donors [306] . TAT ] cyt rise and cell death correlated with the IP 3 R2-expression levels, but not with IP 3 R1-, IP 3 R3-or total IP 3 R-expression levels [307] . As it was already mentioned in Section 2.1.1, IP 3 R2 and IP 3 R3 display the highest and lowest sensitivity to IP 3 respectively. Cancer cells with high IP 3 R2 levels were very sensitive to TAT-IDP S , whereas cancer cells with low IP 3 R2 levels were almost completely resistant to TAT-IDP S treatment. Furthermore, IP 3 R/Bcl-2-complex formation was more prominent in TAT-IDP S -sensitive cancer cells than in TAT-IDP Sresistant cancer cells. Therefore, we propose that cancer cells expressing high IP 3 R2 levels are more "addicted" to the presence of Bcl-2 at the IP 3 R and at the ER Ca 2+ stores than cancer cells expressing low IP 3 R2 levels.
Clearly, the mechanisms that control the differential IP 3 R isoformexpression profile in cancer cells and that contribute to the resistance of cancer cells to TAT-IDP S should be further examined.
Despite the observed differences between Bcl-2 and Bcl-Xl at the level of their BH4 domain, there is clear evidence that Bcl-Xl can also directly bind and modulate IP 3 Rs [190, 206] . Bcl-Xl binding was proposed to occur at the C-terminal domain in the proximity of the Ca 2+ channelpore domain of the IP 3 R [190] with a critical role for the 6th transmembrane domain [305, 308] . Both anti-apoptotic proteins Bcl-2 and Bcl-Xl showed equal binding affinity for the C-terminus of the IP 3 R containing the 6th transmembrane domain [305] . [206] . Consistent with these effects, Bcl-Xl-mediated protection against apoptosis occurred mainly in IP 3 R-expressing DT40-TKO cells, while no protective effect of Bcl-Xl was observed in mock-expressing DT40-TKO cells. All three IP 3 R isoform were able to mediate the Bcl-Xl protective function. Further mechanistic evidence on the enhanced efficiency of the channel opening in response to IP 3 suggested a possible role of two BH3-domain-like structures in the C-terminal tail of IP 3 R in the binding of Bcl-Xl [309] , but this ought to be further investigated. A very recent study revealed a potential mechanism for suppression of the Bcl-Xl-dependent sensitization of the IP 3 R via binding of a phosphorylated K-RAS isoform to the receptor. The authors proposed a model for indirect interaction between Bcl-Xl and phosphorylated K-RAS4B in which both proteins target the C-terminus of the IP 3 R and the formation of this three-molecular complex counteracted Bcl-Xl's sensitizing effects on IP 3 R single-channel activity and subsequent basal Ca 2 + signaling in the mitochondria [310] . Only a phospho-mimetic, but not a phospho-dead or wild-type K-RAS variant was able to block Bcl-Xl's effect on IP 3 Rs and could lower basal mitochondrial Ca 2 + signaling, needed for respiration. Consistent with this, ectopic expression of phospho-mimetic K-RAS4B resulted in autophagy induction in a Bcl-Xl-dependent manner and subsequent toxicity [310] . Finally, similar to Bcl-2 and Bcl-Xl, Mcl-1 also binds to and regulates IP 3 Rs by targeting the C-terminal part, containing the 6th transmembrane domain of the IP 3 R, thereby promoting IP 3 R-mediated prosurvival Ca 2+ oscillations [308] .
Beclin 1
Beclin 1 (ATG6) is a protein essential for the execution of the canonical mTOR-controlled autophagy pathway [311] . Beclin 1 is inhibited by anti-apoptotic Bcl-2 [312, 313] , but phosphorylation events in Beclin 1 and Bcl-2 can disrupt their interaction and can initiate autophagy by recruiting the Vps34 complex [314] [315] [316] [317] . IP 3 Rs contribute to the negative regulation of autophagy by recruiting Beclin 1 and thus limiting the amount of "free" Beclin 1 available for autophagy induction [318] [319] [320] . Binding of Beclin 1 to IP 3 Rs seemed to occur via the IP 3 -binding domain. Both for IP 3 R1 and IP 3 R3, the primary target for Beclin 1 seemed to be the suppressor domain (a.a. 1-225) (Fig. 3) , but also the IP 3 -binding core (a.a. 226-604) showed a specific but weaker interaction with Beclin 1. It was proposed that IP 3 R inhibition by pharmacological tools like xestospongin B or genetic approaches like the use of DT40-TKO cells results in the release of Beclin 1 and enhanced basal autophagy through an AMPK-dependent mechanism correlating with the fact that basal IP 3 R activity suppresses autophagy [174] . Basal IP 3 R activity may fuel Ca 2+ into the mitochondria, thereby promoting the activity of Ca
2+
-dependent enzymes of the Krebs cycle and subsequent ATP production [174, 225] . An independent study showed that the role of the IP 3 R in controlling the basal autophagic flux critically depended on its Ca 2+ -flux properties, since both DT40-TKO cells and DT40-TKO cells expressing a pore-dead mutant of IP 3 R1 displayed elevated LC3-II levels, a marker for autophagy [321] . In this study, however, the mechanism by which IP 3 Rs controlled basal autophagy seemed independent of changes in AMPK and PKB/Akt activity or of Beclin 1/Bcl-2-and Beclin 1/Vps34-complex formation, but was attributed to decreased basal mTOR activity in DT40-TKO cells [321] . These observations seem to indicate a role for basal IP 3 R-mediated Ca 2+ fluxes in sustaining basal mTOR activity, but the mechanisms ought to be further scrutinized.
In addition to this complexity, there seems to be a dual role for IP 3 Rs and Ca 2+ signaling in controlling autophagy [317, 322] /calmodulin-dependent kinase kinase β, an upstream activator of AMPK [323] . While on the one hand IP 3 Rs clearly suppress basal autophagy, IP 3 R activity and sensitization, on the other hand, were critical for driving mTOR-controlled autophagy induced by nutrient starvation or by rapamycin treatment [324, 325] . Recombinantly expressed and purified Beclin 1 was able to sensitize IP 3 R function. In contrast, knocking down Beclin 1 prevented IP 3 R sensitization associated with nutrient starvation. This seemed independent of Beclin 1's essential role in autophagy, since other essential autophagy-dependent gene products that act downstream of Beclin 1 (like ATG5) were not able to prevent IP 3 R sensitization.
G-protein-coupled receptor kinase-interacting proteins 1 and 2 (GIT1 and GIT2)
GIT1 and GIT2 are ubiquitously expressed multi-domain proteins containing an N-terminal ADP ribosylation factor GTPase-activating protein domain, three ankyrin repeats, a spa2-homology domain, a coiled-coil domain and a C-terminal paxillin-binding site (as reviewed in [326] ). Through a complex network of protein interactions, GIT1 and GIT2 control cytoskeletal dynamics, receptor internalization and membrane trafficking [326] . As such, GIT proteins have been implicated in cell migration and tumor invasiveness [327] , chemotactic responses [328] and platelet activation by thrombin [329] . GIT1 has also been implicated in Ca 2+ signaling by interacting with the SH2 domain of PLCγ [330] . The binding of GIT1 to PLCγ was essential for proper PLCγ phosphorylation and activation. Further work revealed another role for GIT1 and GIT2 in Ca 2+ signaling and cell death by directly interacting with the IP 3 R. GIT1 and GIT2 were able to bind to all three IP 3 R isoforms [331] . -store content, respectively. On the other hand, GIT1 and GIT2 knock down increased agonist-induced Ca 2+ signaling.
Knocking down GIT1 was associated with an increase in spontaneous apoptotic cell death and resulted in hypersensitivity towards apoptotic stimuli like staurosporine, which could be suppressed using IP 3 R inhibitors. In contrast, overexpressing GIT1 protected against staurosporineinduced apoptosis. This was abolished for the binding mutant GIT L712A , indicating that GIT1 binding to IP 3 Rs was essential for the protective effect. While all three IP 3 R isoforms are targets of the GIT proteins, complex formation seemed more efficient with IP 3 R1 and IP 3 R2. Hence, the inhibition of IP 3 R1 and IP 3 R2 by the GIT proteins may be more critical to prevent pro-apoptotic Ca 2+ -signaling events, consistent with their ability to produce long-lasting and excessive Ca 2+ oscillations [23] . Although low-level Ca 2+ oscillations are typically associated with a pro-survival outcome and improved mitochondrial bioenergetics [174, 226] , excessive Ca 2+ oscillations may result in cell death [332] .
ROS and thiol modifications of IP 3 Rs
Oxidative stress and the generation of ROS modulate cell survival and cell death, in particular during ischemia/reperfusion injury and inflammatory responses [333] . ROS can modulate IP 3 signaling and IP 3 Rs by the modification of cysteinyl residues, potentially in an IP 3 R isoformdependent manner [334] .
A clear role for IP 3 R1-mediated Ca 2+ release in endothelial-cell death upon ROS produced by lipo-polysaccharide-activated macrophages has been described [335] . 3 Rs is not only isoform specific but also species, since the rat IP 3 R3 isoform ectopically expressed in DT40-TKO cells was sensitized by O 2 · − . The reason for this difference between the chicken and rat IP 3 R3 was attributed to a potential difference in accessibility of evolutionary conserved cysteine residues. Furthermore, oxidative stress has been shown to influence the expression of IP 3 R isoforms. In neuronal cells, it was shown that sublethal tert-butyl hydroperoxide-mediated oxidative stress resulted in increased nuclear Ca 2+ -signaling events, which could be completely prevented by using an IP 3 R inhibitor [337] . At the molecular level, this enhanced Ca 2+ signaling was associated with an increase in the expression level of IP 3 R2 at both the mRNA and protein level, while IP 3 R1 and IP 3 R3 channels or other intracellular Ca
2+
-release mechanisms, like the RyRs and the polycystins, remained unaffected.
Another form of thiol modification of proteins occurs in response to H 2 S signaling, which causes sulfhydration of proteins, thereby converting the SH group of cysteine into an SSH group [338, 339] . Endogenous H 2 S is produced from L-cysteine by cystathionine β-synthase and cystathionine γ-lyase and functions as a physiological vasodilator and regulator of the blood pressure. The H 2 S-producing activity of cystathionine γ-lyase requires cytosolic Ca 2+ and calmodulin, which forms a complex with the enzyme [340] . Recently, chemicals that act either as slow or fast H 2 S donors (GYY4137 and NaSH, respectively) were found to trigger an increase in [Ca 2+ ] cyt and a decrease in the [Ca 2+ ] ER of mammalian cells [341] . The depletion of the ER Ca 2+ stores by these H 2 S donors was associated with ER stress. These events could be partially rescued by inhibiting the IP 3 Rs. The prolonged exposure of the cells to slow H 2 S donors was associated with an increase in the IP 3 R1-and IP 3 R2-expression levels, while the IP 3 R3-expression levels remained unaltered. These changes in IP 3 R1 and IP 3 R2 expression were dependent on thiol modifications, since reducing agents like dithiothreitol could counteract this upregulation. These events were also associated with increased apoptosis and mitochondrial depolarization. Importantly, increased IP 3 R1-and IP 3 R2-mediated signaling and expression levels were responsible for GYY4137-induced cell death, since both IP 3 R inhibitors as well as silencing either IP 3 R1 or IP 3 R2 channels suppressed GYY4137-induced cell death. Altered IP 3 R-isoform expression in combination with increased IP 3 signaling may contribute to H 2 S-induced ER stress and concomitant cell death. The latter phenomenon has been observed in insulinsecreting β cells exposed to H 2 S [342] and may be very relevant for pathologies like diabetes, as pancreatic islets of diabetic mice have been associated with an overproduction of endogenous H 2 S and a concomitant suppression of insulin release [343] . In this context, H 2 S-induced ER stress together with an activation of K ATP channels may result in defective insulin release from β cells [344] . Yet, the role of altered IP 3 R isoform-expression levels during pathological H 2 S signaling in pancreatic β cells under diabetic conditions ought to be further established. However, the effect of H 2 S on IP 3 Rs may be more complex and may not only be stimulatory. For instance, in airway smooth muscle, H 2 S donors reversibly inhibited IICR in response to intracellular IP 3 uncaging and physiological stimuli acting through IP 3 Rs like acetylcholine [345] . Correlating with these effects several H 2 S donors counteracted contractions induced by IP 3 uncaging and caused relaxation in acetylcholine pre-treated and thus pre-constricted airway smooth-muscle cells. These effects could be mimicked by reducing agents and inhibited by oxidizing agents [345] . The reasons for these opposite effects of H 2 S on IP 3 R function are not clear, but could be dependent on differences in IP 3 R isoform-expression levels and differences in H 2 S concentrations and exposure times.
Conclusion
The IP 3 R has emerged as a cellular hub integrating many signaling pathways that control cell fate. It becomes increasingly clear that the various IP 3 R isoforms can be involved in these functions. As these isoforms have slightly different functional properties this allows a fine tuning in the cellular responses, which in some cases critically affects the final cellular decision for proliferation, autophagy or cell death. For a number of basic cellular regulators including IP 3 itself, Ca 2+ and Ca
2+
-binding proteins, ATP and thiol-group modulation, there are several reports about isoform-specific differences. Also with respect to the interaction with regulatory proteins and phosphorylation by protein kinases, isoform specificity has been described. A less well documented matter concerns the isoform specificity of the cellular and subcellular localization of IP 3 Rs, for which no defined pattern is available. This is particularly relevant with respect to the localization in the MAMs, microdomains responsible for a privileged transfer between the ER and the mitochondria. As an efficient transfer of Ca 2+ to the mitochondria is of utmost importance for survival, autophagy or cell death, one can expect that the subtype and regulation of the isoform present in the MAMs is crucial for determining cell fate. Although IP 3 R3 has been reported to be associated with the MAMs [152, 164] , it is not clear whether this is a universal property of all cell types, particularly cancer cells. In this respect, not only IP 3 R-isoform localization and intrinsic properties, but also differential regulation of different isoforms as for example by PKB/Akt, may be crucial to understand the sensitivity of different cancer cells to such treatments.
